SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Rubius Therapeutics, Inc. – IPO: ‘S-1/A’ on 7/2/18 – ‘EX-4.1’

On:  Monday, 7/2/18, at 4:52pm ET   ·   Accession #:  1047469-18-4849   ·   File #:  333-225840

Previous ‘S-1’:  ‘S-1’ on 6/22/18   ·   Next & Latest:  ‘S-1/A’ on 7/9/18   ·   8 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 7/02/18  Rubius Therapeutics, Inc.         S-1/A                  7:1.0M                                   Merrill Corp/New/FA

Initial Public Offering (IPO):  Pre-Effective Amendment to Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Pre-Effective Amendment to Registration Statement   HTML     69K 
                          (General Form)                                         
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML      8K 
 3: EX-10.5     Material Contract                                   HTML     21K 
 4: EX-10.6     Material Contract                                   HTML     88K 
 5: EX-10.7     Material Contract                                   HTML     92K 
 6: EX-10.8     Material Contract                                   HTML     81K 
 7: EX-10.9     Material Contract                                   HTML     82K 


EX-4.1   —   Instrument Defining the Rights of Security Holders


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]




Exhibit 4.1

 

INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE AUTHORIZED: 150,000,000 COMMON STOCK SHARES, $0.001 PAR VALUE PER SHARE SEE REVERSE FOR CERTAIN DEFINITIONS This Certifies That is the owner of Fully Paid and Non-Assessable Common Stock, $0.001 Par Value of RUBIUS THERAPEUTICS, INC. transferable on the books of this Corporation in person or by attorney upon surrender of this Certificate duly endorsed or assigned. This Certificate and the shares represented hereby are subject to the laws of the State of Delaware, and to the Certificate of Incorporation and the Bylaws of the Corporation, as now or hereafter amended. This Certificate is not valid until countersigned by the Transfer Agent. IN WITNESS WHEREOF, the Corporation has caused this Certificate to be signed by the facsimile signatures of its duly authorized officers and to be sealed with the facsimile seal of the Corporation. Dated: a CHIEF EXECUTIVE OFFICER CHIEF FINANCIAL OFFICER Countersigned: AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC 6201 15th Avenue Brooklyn, NY 11219 By Transfer Agent and Registrar Authorized Officer CUSIP 78116T 10 3

 


 

RUBIUS THERAPEUTICS, INC. AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC TRANSFER FEE: AS REQUIRED The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations: TEN COM - as tenants in common TEN ENT - as tenants by the entireties UNIF GIFT MIN ACT - Custodian JT TEN - as joint tenants with right (Cust) (Minor) of survivorship and not as under Uniform Gifts to Minors tenants in common Act (State) Additional abbreviations may also be used though not in the above list. PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE FOR VALUE RECEIVED, hereby sell, assign and transfer unto PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS INCLUDING POSTAL ZIP CODE OF ASSIGNEE Shares of the Common Stock represented by the within Certificate and do hereby irrevocably constitute and appoint Attorney to transfer the said stock on the books of the within-named Corporation, with full power of substitution in the premises. Dated: 20 , Signature: X Signature(s) Guaranteed: Signature: X THE SIGNATURE(S) TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME(S) AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATEVER. THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (Banks, Stockbrokers, Savings and Loan Associations and Credit Unions) WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15.

 



8 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/27/23  Rubius Therapeutics, Inc.         10-K       12/31/22   77:7.2M
11/09/22  Rubius Therapeutics, Inc.         10-Q        9/30/22   58:5.3M
 8/09/22  Rubius Therapeutics, Inc.         10-Q        6/30/22   52:4.8M
 6/08/22  Rubius Therapeutics, Inc.         S-3                    6:1M                                     Toppan Merrill/FA
 5/10/22  Rubius Therapeutics, Inc.         S-8         5/10/22    4:63K                                    Toppan Merrill/FA
 2/25/22  Rubius Therapeutics, Inc.         10-K       12/31/21   74:10M                                    Toppan Merrill Bridge/FA
 5/10/21  Rubius Therapeutics, Inc.         S-8         5/10/21    3:110K                                   Toppan Merrill Bridge/FA
 2/23/21  Rubius Therapeutics, Inc.         10-K       12/31/20   82:12M                                    Toppan Merrill Bridge/FA
Top
Filing Submission 0001047469-18-004849   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 8:04:10.1am ET